DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Propoxyphene Napsylate and Acetaminophen (Propoxyphene Napsylate / Acetaminophen) - Summary

 
 



SUMMARY

Propoxyphene is an opioid analgesic. Acetaminophen is a non-opioid analgesic and antipyretic.

This product is indicated for the relief of mild to moderate pain, either when pain is present alone or when it is accompanied by fever.
See all Propoxyphene Napsylate and Acetaminophen indications & dosage >>

NEWS HIGHLIGHTS

Media Articles Related to Propoxyphene Napsylate and Acetaminophen (Propoxyphene / Acetaminophen)

The Effect of Pain Management Advice on Patient Satisfaction
Source: Medscape Anesthesiology Headlines [2016.07.22]
Does providing pain advice improve patient satisfaction?
Emergency Medicine Journal

Medical News Today: 8 Common Causes of Breast Pain
Source: Featured Health News from Medical News Today [2016.07.22]
Learn about some of the common causes of breast pain. These causes include skin changes, certain types of medication, and infections.

8 Common Causes of Breast Pain
Source: Breast Cancer News From Medical News Today [2016.07.22]
Learn about some of the common causes of breast pain. These causes include skin changes, certain types of medication, and infections.

Pain Raises Risk of Opioid Addiction
Source: MedicineNet Drug Abuse Specialty [2016.07.22]
Title: Pain Raises Risk of Opioid Addiction
Category: Health News
Created: 7/22/2016 12:00:00 AM
Last Editorial Review: 7/22/2016 12:00:00 AM

Biacuplasty vs Conventional Management for Lumbar Back Pain
Source: Medscape Anesthesiology Headlines [2016.07.21]
Is one of these treatment methods for lumbar discogenic pain more effective than the other?
Spine

more news >>

Published Studies Related to Propoxyphene Napsylate and Acetaminophen (Propoxyphene / Acetaminophen)

Analgesic efficacy of tramadol/acetaminophen and propoxyphene/acetaminophen for relief of postoperative wound pain. [2012]
Depain-X in acute postoperative pain... CONCLUSION: Among patients with mild to moderate postoperative wound pain,

Propoxyphene and pain management in the elderly. [2009.11]
Pain is frequently reported and often undertreated in the elderly population.Therefore, it is very important to consider alternatives to propoxyphene such as APAP, nonsteroidal anti-inflammatory drugs (rare use due to adverse effects) and other opioids, when managing elderly patients with pain.

more studies >>

Clinical Trials Related to Propoxyphene Napsylate and Acetaminophen (Propoxyphene / Acetaminophen)

Multiple-Ascending-Dose Study to Evaluate the Safety of Propoxyphene Napsylate In Healthy Adult Subjects [Terminated]

Lumbar Stenosis Outcomes Research II [Completed]
The primary objective of the proposed pilot study is to determine the efficacy of oxymorphone hydrochloride and propoxyphene/acetaminophen combination in prolonging the time to onset of pain and reducing the severity of pain associated with walking in patients with neurogenic intermittent claudication. The secondary objective is to examine the functional benefit of oxymorphone hydrochloride and propoxyphene/acetaminophen combination with respect to improvement in duration and distance of walking tolerance. The proposed study will also provide the foundation for a treadmill-based methodology for assessing the analgesic efficacy of drugs for low back pain provoked by standing and walking associated with lumbar spinal stenosis.

Oxycodone or Standard Pain Therapy in Treating Patients With Cancer Pain [Completed]
RATIONALE: Oxycodone helps lessen pain caused by cancer and may improve quality of life. It is not yet known whether oxycodone works better and is more cost effective than standard therapy in treating patients with cancer pain. PURPOSE: This randomized phase IV trial is studying oxycodone to see how well it works compared with standard pain therapy in treating patients with cancer pain and if it is more cost effective than standard pain therapy.

Effect Of Celecoxib On Hip Osteoarthritis (OA) Progression [Terminated]
Objectives of the study: Primary: Assess the ability of a continuous treatment of celecoxib 200 mg versus placebo administered once daily (QD) for 24 months in slowing disease progression as assessed radiographically in subjects with osteoarthritis (OA) of the hipSecondary: Assess the ability of a continuous treatment of celecoxib 200 mg versus placebo administered QD for 24 months in treating disease signs and symptoms in subjects with OA of the hip. Evaluate the ability of a continuous 24-month intake of celecoxib 200 mg QD versus placebo to reduce number of subjects eligible for hip replacement according to the investigator. Evaluate the tolerability and safety of a continuous 24-month intake of celecoxib 200 mg QD versus placebo in subjects with OA of the hip.

An Effectiveness and Safety Study of Two Doses of Acetaminophen Extended Release Caplets in the Treatment of Osteoarthritis of the Hip or Knee [Completed]
The purpose of this study is to determine the safety and effectiveness of 650 mg and 1300 mg acetaminophen extended release given three times a day for the relief of signs and symptoms of osteoarthritis of the hip or knee for a period of 12 weeks.

more trials >>

Reports of Suspected Propoxyphene Napsylate and Acetaminophen (Propoxyphene / Acetaminophen) Side Effects

Myocardial Infarction (9)Atrial Fibrillation (8)Palpitations (5)Arrhythmia (4)Blood Pressure Inadequately Controlled (3)Transient Ischaemic Attack (3)Blindness (3)Cardiac Arrest (3)Sudden Death (2)Disorientation (2)more >>


Page last updated: 2016-07-22

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2015